Table I.
COVID-19 affected MAR pregnancies (n = 105) | Characteristics according to outcome |
||||
---|---|---|---|---|---|
Live births (n = 67) | Miscarriage (n = 10) | Stillbirth (n = 2) | Maternal death (n = 1) | ||
Diagnosis COVID-19 | |||||
RT-PCR | 97 (92.4%) | 60 (89.5%) | 9 (90.0%) | 2 (100%) | 1 (100%) |
Antibody | 3 (2.9%) | 3 (4.5%) | 0 | 0 | 0 |
Other | 5 (4.8%) | 4 (6.0%) | 1 (10.0%) | 0 | 0 |
Time of diagnosis | |||||
During the MAR treatment (including 15 days after embryo transfer) | 11 (10.5%) | 2 (3.0%) | 3 (30.0%) | 0 | 0 |
First trimester | 32 (30.5%) | 11 (16.4%) | 7 (70.0%) | 0 | 1 (100%) |
Second trimester | 21 (20.0%) | 14 (20.9%) | 0 | 2 (100%) | 0 |
Third trimester (including delivery) | 41 (39.0%) | 40 (59.7%) | 0 | 0 | 0 |
Symptoms | |||||
Asymptomatic | 33 (31.4%) | 24 (35.8%) | 3 (30.0%) | 0 | 0 |
Fever | 42 (40.0%) | 28 (41.8%) | 4 (40.0%) | 1 (50.0%) | 1 (100%) |
Cough | 37 (35.2%) | 23 (34.3%) | 3 (30.0%) | 2 (100%) | 1 (100%) |
Anosmia | 30 (28.6%) | 18 (26.9%) | 3 (30.0%) | 1 (50.0%) | 0 |
Ageusia | 15 (14.3%) | 9 (13.4%) | 4 (40.0%) | 0 | 0 |
Gastrointestinal symptoms | 12 (11.4%) | 8 (11.9%) | 0 | 0 | 0 |
Other | 19 (17.3%) | 15 (22.4%) | 2 (20.0%) | 0 | 0 |
Hospitalization | |||||
None | 72 (68.6%) | 38 (56.7%) | 10 (100%) | 1 (50.0%) | 0 |
General ward | 28 (26.7%) | 25 (37.3%) | 0 | 1 (50.0%) | 0 |
ICU | 2 (1.9%) | 2 (3.0%) | 0 | 0 | 0 |
Respiratory support | 3 (2.9%) | 2 (3.0%) | 0 | 0 | 1 (100%) |
MAR technique | |||||
ART | 67 (63.8%) | 38 (56.7%) | 8 (80.0%) | 0 | 1 (100%) |
Ovulation induction, with or without IUI | 38 (36.2%) | 29 (43.3%) | 2 (20.0%) | 2 (100%) | 0 |
Maternal age | |||||
Mean ± SD age (years)1 | 33.7 ± 6.1a | 33.1 ± 1.7b | 38.0 ± 2.6c | 34.0d | 25.0e |
Data are represented as numbers and percentages.
COVID-19, coronavirus disease 2019; ICU, intensive care unit; MAR, medically assisted reproduction; RT-PCR, real-time PCR.
Data available for 81a, 58b, 7c, 1d and 1e cases.